Atricure reports third quarter 2022 financial results

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management and post-operative pain management, today announced third quarter 2022 financial results.
ATRC Ratings Summary
ATRC Quant Ranking